secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2025-03-04T23:59:59+00:00
Accession:  0001425450-25-000012
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics reports record FY2024 revenue of $204.7M, up 38% YoY; Q4 adjusted EBITDA doubles to $3.0M
--------------------------------------------------------------------------------

- Full year 2024 revenue $204.7M, up 38% from $148.7M in 2023; Q4 revenue $52.7M, up 40% YoY.
- Full year adjusted EBITDA $8.5M vs $5.0M in 2023; Q4 adjusted EBITDA $3.0M, more than double $1.3M.
- Net loss widened to $37.8M in 2024 from $21.0M in 2023; Q4 net loss $16.1M ($0.69/sh) vs $6.7M ($0.29/sh).
- FY2025 guidance: revenue $235-242M (15-18% growth), adjusted EBITDA $15-17M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545025000012/0001425450-25-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545025000012/kids-20250304.htm
  HTML page:      https://secwatch.observer/filing/0001425450-25-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer